Overview
Maria Sammarco practices in Rome, Italy. Ms. Sammarco is highly rated in 5 conditions, according to our data. Her top areas of expertise are Uveal Melanoma, Melanoma of the Eye, Melanoma, Metastatic Uveal Melanoma, and Vitrectomy.
Her clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Uveal MelanomaMs. Sammarco isDistinguished. Learn about Uveal Melanoma.
- Advanced
- MelanomaMs. Sammarco isAdvanced. Learn about Melanoma.
- Melanoma of the EyeMs. Sammarco isAdvanced. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaMs. Sammarco isAdvanced. Learn about Metastatic Uveal Melanoma.
- VitrectomyMs. Sammarco isAdvanced. Learn about Vitrectomy.
- Experienced
- Age-Related Macular Degeneration (ARMD)Ms. Sammarco isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Central Serous ChorioretinopathyMs. Sammarco isExperienced. Learn about Central Serous Chorioretinopathy.
- ChemosisMs. Sammarco isExperienced. Learn about Chemosis.
- Lacrimal Gland TumorMs. Sammarco isExperienced. Learn about Lacrimal Gland Tumor.
- Late-Onset Retinal DegenerationMs. Sammarco isExperienced. Learn about Late-Onset Retinal Degeneration.
- Orbital PseudotumorMs. Sammarco isExperienced. Learn about Orbital Pseudotumor.